Markets:

Overview

News

Currencies

International

Treasuries

Arbutus Biopharma Corporation - Common Stock (NQ:ABUS)

4.220 -0.210 (-4.74%)

Streaming Delayed Price Updated: 3:15 PM EDT, Apr 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arbutus Biopharma Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs ↗

June 20, 2021

Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal...

Via Benzinga

24 Stocks Moving in Friday's Pre-Market Session ↗

June 04, 2021

Gainers Senseonics Holdings, Inc. (NYSE: SENS) rose 37.1% to $2.81 in pre-market trading after the company disclosed results from a PROMISE study evaluating its Eversense CGM...

Via Benzinga

The Battle Over Covid Vaccine Patents Begins — What It Could Mean For Biotech ↗

May 20, 2021

Experts say a patent waiver for coronavirus shots wouldn't just pressure Covid vaccine stocks, it could also staunch innovation for biotech companies.

Via Investor's Business Daily

Topics Intellectual Property

Why Arbutus Biopharma's Stock Is Trading Lower Today ↗

May 05, 2021

Arbutus Biopharma's Stock Price And Volume Action Arbutus Biopharma's (NASDAQ:

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

28 Stocks Moving in Friday's Pre-Market Session ↗

May 14, 2021

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 28.5% to $0.7451 in pre-market trading after the company reported better-than-expected Q1 sales. Bionano Genomics, Inc. (NASDAQ:...

Via Benzinga

'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines ↗

May 08, 2021

Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs. Here is a look back at the week in SPACs for...

Via Benzinga

Arbutus Biopharma (ABUS) Q1 2021 Earnings Call Transcript ↗

May 06, 2021

ABUS earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Roivant Sciences Gets SPAC Deal: What To Expect From This BioPharma, Health Technology Company ↗

May 03, 2021

A drug discovery company with ownership stakes in several public and private biopharmaceutical companies is going public with a SPAC deal announced Monday morning. The SPAC Deal:...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.